BRIEF-Adaptive Biotechnologies Corp And Neogenomics Announce Strategic Collaboration

Reuters

14 Jan

Adaptive Biotechnologies Corp2.79%

Jan 14 (Reuters) - Adaptive Biotechnologies Corp ADPT.O:

ADAPTIVE BIOTECHNOLOGIES CORP: CO AND NEOGENOMICS ANNOUNCE STRATEGIC COLLABORATION
ADAPTIVE BIOTECHNOLOGIES AND NEOGENOMICS PARTNER TO EXPAND ACCESS TO PERSONALIZED DISEASE MONITORING FOR BLOOD CANCER PATIENTS
ADAPTIVE BIOTECHNOLOGIES CORP: SPECIFIC FINANCIAL TERMS OF AGREEMENT ARE NOT DISCLOSED

Source text: ID:nGNX7WqR3r

Further company coverage: ADPT.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

no data

No relevant data is available

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2503156524"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2503156524\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2503156524?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-14 20:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2503156524","market":"us","top_or_hot":-1,"title":"BRIEF-Adaptive Biotechnologies Corp And Neogenomics Announce Strategic Collaboration","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/ADPT\">Adaptive Biotechnologies Corp</a> And Neogenomics Announce Strategic Collaboration</title></head><body><p><span>Jan 14 (Reuters)</span><span> - </span>Adaptive Biotechnologies Corp <span>ADPT.O</span>:</p><ul><li><p>ADAPTIVE BIOTECHNOLOGIES CORP: CO AND NEOGENOMICS ANNOUNCE STRATEGIC COLLABORATION</p></li><li><p>ADAPTIVE BIOTECHNOLOGIES AND NEOGENOMICS PARTNER TO EXPAND ACCESS TO PERSONALIZED DISEASE MONITORING FOR BLOOD CANCER PATIENTS</p></li><li><p>ADAPTIVE BIOTECHNOLOGIES CORP: SPECIFIC FINANCIAL TERMS OF AGREEMENT ARE NOT DISCLOSED</p></li></ul><p>Source text: <span>ID:nGNX7WqR3r</span></p><p>Further company coverage: <span>ADPT.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Adaptive Biotechnologies Corp And Neogenomics Announce Strategic Collaboration</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Adaptive Biotechnologies Corp And Neogenomics Announce Strategic Collaboration\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-01-14 20:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/ADPT\">Adaptive Biotechnologies Corp</a> And Neogenomics Announce Strategic Collaboration</title></head><body><p><span>Jan 14 (Reuters)</span><span> - </span>Adaptive Biotechnologies Corp <span>ADPT.O</span>:</p><ul><li><p>ADAPTIVE BIOTECHNOLOGIES CORP: CO AND NEOGENOMICS ANNOUNCE STRATEGIC COLLABORATION</p></li><li><p>ADAPTIVE BIOTECHNOLOGIES AND NEOGENOMICS PARTNER TO EXPAND ACCESS TO PERSONALIZED DISEASE MONITORING FOR BLOOD CANCER PATIENTS</p></li><li><p>ADAPTIVE BIOTECHNOLOGIES CORP: SPECIFIC FINANCIAL TERMS OF AGREEMENT ARE NOT DISCLOSED</p></li></ul><p>Source text: <span>ID:nGNX7WqR3r</span></p><p>Further company coverage: <span>ADPT.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ADPT","symbol_name":"Adaptive Biotechnologies Corp","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250114:nFWN3OA0CN:1","article_id":"2503156524","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2503156524","pubTimestamp":1736857961,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Adaptive Biotechnologies Corp And Neogenomics Announce Strategic CollaborationJan 14 (Reuters) - Adaptive Biotechnologies Corp ADPT.O:ADAPTIVE BIOTECHNOLOGIES CORP: CO AND NEOGENOMICS ANNOUNCE S","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ADPT":"Adaptive Biotechnologies Corp","LU0106261612.USD":"SCHRODER ISF US SMALLER COMPANIES IMPACT \"A\" ACC","BK4196":"保健护理服务","BK4121":"生命科学工具和服务","NEO":"NeoGenomics","LU0012050646.USD":"SCHRODER ISF US SMALLER COMPANIES IMPACT \"A\" (USD) INC AV"},"translate_title":"简介-Adaptive Biotechnologies Corp和Neogenomics宣布战略合作","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ADPT":0.9,"NEO":0.9},"content_text":"BRIEF-Adaptive Biotechnologies Corp And Neogenomics Announce Strategic CollaborationJan 14 (Reuters) - Adaptive Biotechnologies Corp ADPT.O:ADAPTIVE BIOTECHNOLOGIES CORP: CO AND NEOGENOMICS ANNOUNCE STRATEGIC COLLABORATIONADAPTIVE BIOTECHNOLOGIES AND NEOGENOMICS PARTNER TO EXPAND ACCESS TO PERSONALIZED DISEASE MONITORING FOR BLOOD CANCER PATIENTSADAPTIVE BIOTECHNOLOGIES CORP: SPECIFIC FINANCIAL TERMS OF AGREEMENT ARE NOT DISCLOSEDSource text: ID:nGNX7WqR3rFurther company coverage: ADPT.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1}}}

If the download button clicks without skipping, click on the top right menu and select "Open in Browser."

Consult now
Download APP
Scan QR code to download the app.